Erick Lucera

Erick Lucera

Former Executive Vice President and Chief Financial OfficeratEditas Medicine· In proxies 2023–2024

Pay in FY2024-18% from the year before · Editas Medicine stock -87.5% the same year

Erick Lucera was paid $1.8M in FY2024 (Dec), down 18%. Editas Medicine stock fell 87.5% that year.

Pay$100 in the stock at the end of FY22 → $14
Pay is from the Summary Compensation Table of each Editas Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Editas MedicinePublic company · 3 yr
    • Former Executive Vice President and Chief Financial Officer2023 – Present · 3 yrStock in role -65%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?